[1]马胜辉,崔雪琴,李建华,等.结直肠癌组织miR-485-5p，miR-1207-3p和miR-590-3p水平表达与临床病理特征及生存的相关性研究[J].现代检验医学杂志,2022,37(03):16-20.[doi:10.3969/j.issn.1671-7414.2022.03.004]
　MA Sheng-hui,CUI Xue-qin,LI Jian-hua,et al.Correlation of miR-485-5p, miR-1207-3p, miR-590-3p Level Expression and Clinicopathologic Characteristics and Survival in Colorectal Cancer Tissue[J].Journal of Modern Laboratory Medicine,2022,37(03):16-20.[doi:10.3969/j.issn.1671-7414.2022.03.004]
点击复制

结直肠癌组织miR-485-5p，miR-1207-3p和miR-590-3p水平表达与临床病理特征及生存的相关性研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第37卷
期数:
2022年03期
页码:
16-20
栏目:
论　著
出版日期:
2022-05-15

文章信息/Info

Title:
Correlation of miR-485-5p, miR-1207-3p, miR-590-3p Level Expression and Clinicopathologic Characteristics and Survival in Colorectal Cancer Tissue
文章编号:
1671-7414（2022）03-016-06
作者:
马胜辉1; 崔雪琴2; 李建华1; 王　翔1
（1. 承德市中心医院肿瘤科, 河北承德067000；2. 河北省老年病医院中西医结合科，石家庄050011）
Author(s):
MA Sheng-hui1; CUI Xue-qin2;  LI Jian-hua1;  WANG Xiang1
（1.Department of Oncology，Central Hospital of Chengde City, Hebei Chengde 067000，China；2.Department of Integrative Traditional Chinese and Western Medicine, Hebei Geriatric Hospital, Shijiazhuang 050011，China）
关键词:
结直肠癌; 微小核糖核酸-485-5p; 微小核糖核酸-1207-3p; 微小核糖核酸-590-3p
分类号:
R735.3；R730.43
DOI:
10.3969/j.issn.1671-7414.2022.03.004
文献标志码:
A
摘要:
目的　研究 miR-485-5p，miR-1207-3p和 miR-590-3p在结直肠癌演进过程中的表达变化。方法　选取 2019年 1月～ 2020年 1月承德市中心医院病理科归档资料齐全完整的 84例结直肠癌组织石蜡标本和距离癌组织边缘 5cm的癌旁组织石蜡标本。采用免疫组织化学法及荧光定量 PCR法检测以直肠组织制作的标本 miR-485-5p，miR-1207-3p和 miR-590-3p，分析 miR-485-5p，miR-1207-3p和 miR-590-3p在结直肠癌组织演进过程中的表达变化。结果　癌组织 miR-485-5p(3.25±0.32 fmol/L)，miR-1207-3p(1.45±0.14 fmol/L)和 miR-590-3p(2.63±0.26 fmol/L)表达均低于癌旁组织 (7.65±0.76 fmol/L，5.81±0.58 fmol/L，8.95±0.89 fmol/L)，差异有统计学意义（ t=48.900，66.970, 62.470，均 P＜ 0.05)。Ⅲ～Ⅳ期、中、低分化、有淋巴结转移、有肝转移患者 miR-485-5p，miR-1207-3p和 miR-590-3p表达分别低于Ⅰ～Ⅱ期、高分化、无淋巴结转移、无肝转移患者，差异有统计学意义（ t/F=21.338～ 52.835, 均 P＜ 0.05）。死亡组患者 miR-485-5p（1.52±0.15 fmol/L），miR-1207-3p（0.50±0.05 fmol/L）和 miR-590-3p（1.15±0.11 fmol/L）均低于存活组（4.98±0.49 fmol/L，2.40±0.24 fmol/L，4.11±0.41 fmol/L），差异具有统计学意义（t=27.820，31.370, 28.520，均 P＜ 0.05）。 ROC曲线分析显示，三项联合曲线下面积、敏感度和特异度分别为 0.823，86.30%和 87.32%；miR-485-5p分别为 0.699，85.78%和 86.41%；miR-1207-3p分别为 0.768，85.59%和 71.14%；miR-590-3p分别为 0.719，83.62%和 87.62%，三项联合诊断价值大于单独检测。 miR-485-5p，miR-1207-3p和 miR-590-3p之间相关性分析显示， miR-485-5p与 miR-12073p呈正相关（ r=0.457，P=0.005）；miR-485-5p与 miR-590-3p呈正相关（ r=0.314，P=0.003）；miR-1207-3p与 miR590-3p呈正相关（ r=0.332，P=0.002）。结论　血清 miR-485-5p，miR-1207-3p和 miR-590-3p水平联合检测对诊断结直肠癌、判断恶化程度有一定临床价值，且可能作为结直肠癌患者潜在的预后标志物。
Abstract:
Objective　To investigate the expression changes of miR-485-5p, miR-1207-3p and miR-590-3p during the progression of colorectal cancer. Methods　The archive information which was complete full of 84 cases of colorectal cancer tissue paraffin specimens and 5cm of cancerous tissue edge tissue adjacent to carcinoma specimens of paraffin was selected in Department of Pathology, Central Hospital of Chengde City from January 2019 to January 2020. Used the immunohistochemical method and fluorescence quantitative PCR method to detect miR-485-5p, miR-1207-3p, miR-590-3p, analysis of miR-485-5p, miR-1207-3p and miR-590-3p in the expression changes in the process of evolution of colorectal cancer in the organization. Results　The expressions of miR-485-5p (3.25±0.32 fmol/L), miR-1207-3p (1.45±0.14 fmol/L) and miR-590-3p (2.63±0.26 fmol/L) in cancer tissues were all lower than in the tissues adjacent to the cancerous tissue(7.65±0.76 fmol/L，5.81±0.58 fmol/ L，8.95±0.89 fmol/L),the differences were statistically significant（t=48.900，66.970, 62.470，all P ＜ 0.05).The expressions of miR-485-5p, miR-1207-3p and miR-590-3p in patients with stage Ⅲ～Ⅳ , moderately and poorly differentiated, lymph node metastasis and liver metastasis were lower than those of stage Ⅰ～Ⅱ , well differentiated, no lymph node metastasis and the patients without liver metastasis, the differences were statistically significant （t/F=21.338 ～ 52.835, all P ＜ 0.05）. The miR- 485-5p（1.52±0.15 fmol/L）,miR-1207-3p（0.50±0.05 fmol/L）and miR-590-3p（1.15±0.11 fmol/L） of the death group were lower than those of the survival group（4.98±0.49 fmol/L，2.40±0.24 fmol/L，4.11±0.41 fmol/L）, and the differences were statistically significant （t=27.820, 31.370, 28.520, all P ＜ 0.05）.ROC curve analysis showed that the area under the three joint curves, sensitivity and specificity were 0.823, 86.30% and 87.32% respectively. MiR-485-5p was 0.699, 85.78% and 86.41% respectively.MiR-1207-3p was 0.768, 85.59% and 71.14% respectively.MiR-590-3p were 0.719, 83.62% and 87.62% respectively.Three associations had high predictive value for colorectal cancer. Correlation analysis between miR-485-5p, miR- 1207-3p and miR-590-3p revealed a positive correlation between miR-485-5p and miR-1207-3p (r=0.457, P=0.005). A positive correlation was observed between miR-485-5p and miR-590-3 (r=0.314, P=0.003),and a positive correlation was observed between miR-1207-3p and miR-590-3p (r=0.332, P=0.002). Conclusion　The combined detection of serum miR-485-5p, miR- 1207-3p and miR-590-3p levels has a certain clinical value in the diagnosis of colorectal cancer and the degree of deterioration, and may be used as a potential prognostic marker for patients with colorectal cancer.

参考文献/References:

[1] 陈培, 邓钦木, 李丹丹. 血浆Septin9 甲基化检测在结直肠癌中的诊断价值[J]. 现代检验医学杂志, 2020, 35(4):10-13． CHEN Pei, DENG Qinmu, LI Dandan. Diagnostic value of plasma Septin9 methylation in screening of colorectal cancer [J]. Journal of Modern Laboratory Medicine, 2020, 35(4):10-13．
[2] 白盈盈, 朱光旭, 潘兴华. 长链非编码RNA 对结直 肠癌潜在诊断价值的研究进展[J]. 现代检验医学杂 志, 2018, 33(1):161-164. BAI Yingying, ZHU Guangxu, PAN Xinghua. Research progress in the potential diagnosis value of long-chain non - encoded RNA for colorectal cancer [J].Journal of Modern Laboratory Medicine, 2018, 33(1):161-164
[3] THANIKACHALAM K, KHAN G. Colorectal cancer and nutrition[J]. Nutrients, 2019, 11(1): 164.
[4] ZHANG Zhan, LI Xuyang, LI Aipeng, et al. MiR- 485-5p suppresses schwann cell proliferation and myelination by targeting cdc42 and Rac1[J]. Experimental Cell Research, 2020, 388(1): 111803.
[5] 井丰军, 倪勇. 结直肠癌患者外周血NLR 与RDW 的变化及临床意义[J]. 现代检验医学杂志, 2018, 33 (3):99-102. JING Fengjun, NI Yong. Change and significance of neutrophil/lymphocyte ratio and red blood cell distribution width of peripheral blood in the colorectal cancer [J]. Journal of Modern Laboratory Medicine, 2018,33(3):99-102.
[6] DEKKER E, TANIS P J, VLEUGELS J LA, et al. Colorectal cancer[J]. Lancet, 2019, 394(10207): 1467- 1480.
[7] 史敏, 郭晓波, 李思远, 等．结直肠癌患者组织中 K-ras 和BRAF 基因突变与不同病理特征的相关性 分析[J]. 现代检验医学杂志, 2018 ,33(3):27-30. SHI Min, GUO Xiaobo, LI Siyuan, et al. Correlation of K-ras and BRAF mutations with pathological features in patients with colorectal cancer [J]. Journal of Modern Laboratory Medicine, 2018 ,33(3):27-30.
[8] 国家癌症中心中国结直肠癌筛查与早诊早治指南制 定专家组．中国结直肠癌筛查与早诊早治指南(2020, 北京)[J]. 中国肿瘤, 2021, 30(1):1-28. National Cancer Center,China,Expert Group of the Development of China Guideline for the Screening,Early Detection and Early Treatment of Colorectal Cancer. China guideline for the screening, early detection and early treatment of colorectal cancer (2020, Beijing) [J]. China Cancer, 2021, 30(1):1-28.
[9] 陈莎, 刘永平. 免疫组化法用于肿瘤患者病理诊断 的效果评价[J]. 当代医学, 2020 ,26 (25):18-19. CHEN Sha, LIU Yongping. Evaluation of the effect of immunohistochemistry on pathological diagnosis of tumor patients [J]. Contemporary Medicine, 2020 ,26 (25):18-19．
[10] 田慧香, 马婕群, 张彦兵, 等. 肿瘤相关巨噬细胞在 结直肠癌转移及治疗中的作用[J]. 医学综述, 2021, 27(3):498-502, 507. TIAN Huixiang, MA Jiequn, ZHANG Yanbing , et al. Role of tumor-associated macrophages in metastasis and treatment of colorectal cancer [J].Medical Recapitulate, 2021, 27(3):498-502, 507.
[11] WONG S H, YU J. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications[J]. Nature Reviews Gastroenterology & Hepatology, 2019, 16(11): 690-704.
[12] 张筱东, 谢星星, 李佳, 等. 血清外泌体miR-221 和 miR-378 水平检测在胃癌诊断中的应用研究[J]. 现 代检验医学杂志, 2020, 35(6):52-55. ZHANG Xiaodong, XIE Xingxing, LI Jia, et al. Application study of serum exosome miR-221 and miR-378 detection in the diagnosis of gastric cancer [J]. Journal of Modern Laboratory Medicine, 2020, 35(6):52-55.
[13] 郑瑞, 张新, 聂明明, 等.CircKRT17 与miR-485-5p 互作调控Wnt/β-catenin 通路影响胃癌发生发展的机 制研究[J]. 临床和实验医学杂志, 2020, 12(6):565-570. ZHENG Rui, ZHANG Xin, NIE Mingming, et al. Mechanism of the interaction between circular RNA KRT17 and miR-485-5p to regulate Wnt/β-catenin signaling pathway and affect the progression of gastric cancer [J]. Journal of Clinical and Experimental Medicine, 2020, 12(6):565-570.
[14] 胡秀秀, 潘玉琴, 王书奎．MicroRNA-485-5p 抑制 人结直肠癌细胞增殖和侵袭作用的研究[J]. 东南大 学学报（医学版）, 2018, 37(5):814-819. HU Xiuxiu, PAN Yuqin , WANG Shukui . Study on the role of microRNA-485-5p inhibitting proliferation and invasion of human colorectal cancer cells [J]. Journal of Southeast University (Medical Edition), 2018, 37(5):814-819.
[15] PIAWAH S, VENOOK A P. Targeted therapy for colorectal cancer metastases: A review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer[J]. Cancer, 2019, 125(23): 4139-4147.
[16] 陈安玥, 李志高．miR-485-5p 在恶性肿瘤中的研究 进展[J]. 现代肿瘤医学, 2018, 26(15):2464-2467. CHEN Anyue, LI Zhigao. Research progress of miR- 485-5p in malignant tumors [J]. Journal of Modern Oncology, 2018, 26(15):2464-2467.
[17] JANNEY A, POWRIE F, MANN E H. Host-microbiota maladaptation in colorectal cancer[J]. Nature, 2020, 585(7826): 509-517.
[18] 宋韬, 周颖, 吴煌福, 等.MiR-1207-3p 靶向XRCC6 对结直肠癌细胞HT-29 凋亡的影响[J]. 转化医学杂 志, 2020, 9(3):142-146. SONG Tao, ZHOU Ying, WU Huangfu, et al. Effect of miR-1207-3p targeting XRCC6 on apoptosis of colorectal cancer cell line HT-29 [J]. Translational Medicine Journal, 2020, 9(3):142-146.
[19] WROBEL P, AHMED S. Current status of immunotherapy in metastatic colorectal cancer[J]. International Journal of Colorectal Disease, 2019, 34(1): 13-25.
[20] 朱利芹, 冯莹, 曹惠芳, 等.MiR-1207-3p 靶向XRCC6 对结直肠癌细胞HT-29 凋亡的影响研究[J]. 贵州医 药, 2021, 45(1):10-12. ZHU Liqin, FENG Ying, CAO Huifang , et al. Influence study on miR-1207-3p targeted regulation of XRCC6 on colorectal cancer cell HT-29 apoptosis [J]. Guizhou Medical Journal, 2021, 45(1):10-12.
[21] No Authors Listed .Colorectal cancer screening[J]. Medical Letter Drugs and Therapeutics, 2019, 61(1575):97-99.
[22] 徐明, 唐澍, 刘琦, 等．MiR-590-3p 对结直肠癌细 胞顺铂耐药的影响及其机制[J]. 山东医药, 2020, 60 (11):6-10. XU Ming, TANG Shu, LIU Qi, et al. Effect of miR- 590-3p on cisplatin resistance of colorectal cancer cells and its mechanism [J]. Shandong Medical Journal, 2020, 60(11):6-10.

相似文献/References:

[1]陈建国.结直肠癌患者FOLFOX化疗与GSTP1,XRCC1基因多态性的研究[J].现代检验医学杂志,2016,31(05):66.[doi:10.3969/j.issn.1671-7414.2016.05.017]
　CHEN Jian-guo.Relationship between FOLFOX Chemotherapy of Colorectal Cancer Patients and GSTP1,XRCC1 Gene Polymorphism[J].Journal of Modern Laboratory Medicine,2016,31(03):66.[doi:10.3969/j.issn.1671-7414.2016.05.017]
[2]周秋媛,王红莉,李虹,等.NRP-1和NRP-2在结直肠癌组织中的表达水平及临床意义[J].现代检验医学杂志,2016,31(06):85.[doi:10.3969/j.issn.1671-7414.2016.06.024]
　ZHOU Qiu-yuan,WANG Hong-li,LI Hong,et al.Serum NRP-1 and NRP-2 Expression in Colorectal Cancer Patients and Its Relationship with Clinical Pathology[J].Journal of Modern Laboratory Medicine,2016,31(03):85.[doi:10.3969/j.issn.1671-7414.2016.06.024]
[3]史 敏,郭晓波,李思远,等.结直肠癌患者组织中K-ras和BRAF基因突变与不同病理特征的相关性分析[J].现代检验医学杂志,2018,33(03):27.[doi:10.3969/j.issn.1671-7414.2018.03.009]
　SHI Min,GUO Xiao-bo,LI Si-yuan,et al.Correlation of K-ras and BRAF Mutations with Pathological Features in Patients with Colorectal Cancer[J].Journal of Modern Laboratory Medicine,2018,33(03):27.[doi:10.3969/j.issn.1671-7414.2018.03.009]
[4]井丰军,倪勇.结直肠癌患者外周血NLR与RDW的变化及临床意义[J].现代检验医学杂志,2018,33(03):99.[doi:10.3969/j.issn.1671-7414.2018.03.025]
　JING Feng-jun,NI Yong.Change and Significance of Neutrophil/Lymphocyte Ratio and Red Blood Cell Distribution Width of Peripheral Blood in the Colorectal Cancer[J].Journal of Modern Laboratory Medicine,2018,33(03):99.[doi:10.3969/j.issn.1671-7414.2018.03.025]
[5]滕祥云,王新梦,刘　维,等.中国汉族结直肠癌患者 UGT1A1*28基因多态性分析[J].现代检验医学杂志,2019,34(06):20.[doi:10.3969 ／ j.issn.1671-7414.2019.06.005]
　TENG Xiang-yun,WANG Xin-meng,LIU Wei,et al.Polymorphism of UGT1A1*28 Gene in Han Patients with Colorectal Cancer in China[J].Journal of Modern Laboratory Medicine,2019,34(03):20.[doi:10.3969 ／ j.issn.1671-7414.2019.06.005]
[6]陈 培,邓钦木,李丹丹.血浆Septin9 甲基化检测在结直肠癌中的诊断价值[J].现代检验医学杂志,2020,35(04):10.[doi:10.3969/j.issn.1671-7414.2020.04.003]
　CHEN Pei,DENG Qin-mu,LI Dan-dan.Diagnostic Value of Plasma Septin9 Methylation in Screening of Colorectal Cancer[J].Journal of Modern Laboratory Medicine,2020,35(03):10.[doi:10.3969/j.issn.1671-7414.2020.04.003]
[7]杨婕琳a,陈文婷b,胡晓利a.结直肠癌组织中硫氧还蛋白-1与硫氧还蛋白互作蛋白的表达及其临床意义[J].现代检验医学杂志,2021,36(06):22.[doi:10.3969/j.issn.1671-7414.2021.06.005]
　YANG Jie-lin,CHEN Wen-ting,HU Xiao-li.Expression and Clinical Significance of Thioredoxin-1 and Thioredoxin Interacting Protein in Colorectal Cancer[J].Journal of Modern Laboratory Medicine,2021,36(03):22.[doi:10.3969/j.issn.1671-7414.2021.06.005]
[8]胡道军,史文杰,孙 敏.LncRNA NEAT1/miR-23b-3p/KLF3 轴调控结直肠癌细胞的生物学功能研究[J].现代检验医学杂志,2022,37(04):1.[doi:10.3969/j.issn.1671-7414.2022.04.001]
　HU Dao-jun,SHI Wen-jie,SUN Min.LncRNA NEAT1/miR-23b-3p/ KLF3 Axis Regulates the Biological Function of Colorectal Cancer Cells[J].Journal of Modern Laboratory Medicine,2022,37(03):1.[doi:10.3969/j.issn.1671-7414.2022.04.001]
[9]冯 芬.结直肠癌组织中USP11 和PPP1CA 表达水平与临床病理的相关性研究[J].现代检验医学杂志,2022,37(04):43.[doi:10.3969/j.issn.1671-7414.2022.04.009]
　FENG Fen.Correlation between USP11 and PPP1CA Expression Levels and Clinicopathology in Colorectal Cancer Tissues[J].Journal of Modern Laboratory Medicine,2022,37(03):43.[doi:10.3969/j.issn.1671-7414.2022.04.009]
[10]郑光明,孙建华,宋秋月.结直肠癌组织中锌指蛋白139（ZNF139）的表达及临床意义研究[J].现代检验医学杂志,2022,37(04):107.[doi:10.3969/j.issn.1671-7414.2022.04.021]
　ZHENG Guang-ming,SUN Jian-hua,SONG Qiu-yue.Expression and Clinical Significance of Zinc Finger Protein 139 (ZNF139) in Colorectal Cancer[J].Journal of Modern Laboratory Medicine,2022,37(03):107.[doi:10.3969/j.issn.1671-7414.2022.04.021]

备注/Memo

备注/Memo:
基金项目：河北省医学科学研究课题（20211022），资助单位：河北省卫生健康委员会。
作者简介：马胜辉（1983-），男，本科，副主任医师，研究方向：胃肠肿瘤外科，E-mail：hnt985329@21cn.com。
更新日期/Last Update: 1900-01-01